相关实验视频

Updated: Sep 11, 2025

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

肝细胞癌中的免疫疗法与伦瓦提尼布:需要精细数据和前性验证

Qi-Feng Chen¹, Song Chen¹, Xiong-Ying Jiang²

¹Department of Minimally Invasive Interventional Therapy, Liver Cancer Study and Service Group, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.

Journal for immunotherapy of cancer

|August 13, 2025

概括

对先进的肝细胞癌 (HCC) 的第一线治疗方法进行比较,伦瓦替尼和免疫疗法在现实研究中显示出相矛盾的生存结果. 需要进一步的研究来个性化治疗策略,以获得更好的患者结果.

科学领域:

肝病学肝病学是一种肝病学.
在瘤学瘤学.
临床试验临床试验

背景情况:

肝细胞癌 (HCC) 是全球癌症死亡的主要原因.
系统疗法对于先进的HCC管理至关重要.
伦瓦提尼布一直是标准的第一线治疗,但免疫疗法组合正在出现.

研究的目的:

为了比较伦瓦提尼布与较新的免疫疗法方案在一线先进的HCC治疗中的有效性.
解决回顾性和现实世界的研究中相互矛盾的发现.
确定未来研究的需求,以优化HCC治疗选择.

主要方法:

审查和综合最近的回顾性和现实世界的研究.
从元分析和目标试验模拟中分析相互矛盾的数据.
确定现有比较研究中的局限性.

主要成果:

回顾性研究显示,伦瓦替尼与免疫疗法的有效性相关的结果各不相同.
一些现实世界的分析表明,伦瓦替尼和阿特佐利祖马布-贝瓦西祖马布的生存率相似.
目标试验模拟表明免疫治疗的结果更好.

结论:

目前关于一线先进HCC治疗的证据是相互矛盾的,并且受研究设计的限制.
局限性包括缺少的临床数据,多样化的治疗方案和混因素.
具有全面数据的前性,病因学分层研究对于个性化治疗选择至关重要.

关键词:

肝细胞癌肝细胞癌免疫治疗是一种免疫疗法.

更多相关视频

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...